Conceptual Development of Industrial Biotechnology for Commercial Production of Vaccines and Biopharmaceuticals
Basanta Kumara Behera
Mar 2023 · Elsevier
E-kitap
310
Sayfa
family_home
Uygun
info
reportPuanlar ve yorumlar doğrulanmaz Daha Fazla Bilgi
Bu e-kitap hakkında
Conceptual Development of Industrial Biotechnology for Commercial Production of Biopharmaceuticals and Vaccines provides insights on how to bring sustainability into biologic drug production. The cumulative facts and figures within in the book are helpful to promoters in monitoring value chain transfer process of super quality biologics for better return in profits. In addition, this is a useful reference for students, researchers and scientists in biotechnology, pharmaceutical science, medical sciences, and the R&D division of biotechnology-based industries. Conceptual development of biotechnology has taken new avenues with the integration of medical sciences, physical science, and engineering, hence this is a timely source. The current global market for vaccines, especially COVID-19, is tremendous. Bivalent oral polio vaccine, diphtheria, tetanus-containing, and measles-containing vaccines have a high demand internationally and recombinant DNA technology and protein engineering are helpful in the production of quality bio-products. - Informs how biotechnology and pharmaceutical industries act as central pillars for the stable production of value-added biological drugs and vaccines from genetically engineered suitable vectors like microbe or cell lines from animals, mammals or plants - Highlights various traditional and modern techniques used for improvising the quality of suitable vectors to produce biologic drugs and vaccines under GMP manufacturing facilities - Provides updated information on the latest microchip-based bioreactors, disposable bag bioreactors, and animal systems as bioreactors to produce biologic drugs like Smart Biomolecules (next generation therapeutics), Bio-similar drugs, Bio-betters, and antibody-drug conjugates - Explains how the closed bioreactors with proper mechanical amendments are used for vaccine production
Yazar hakkında
Dr. Basanta Kumara Behera was a Professor of Biotechnology at three distinguished Indian universities, where he taught and conducted research at the post-graduate level on medical biotechnology, biopharmaceutical, microbial process development, drug designing, bio-energy management, and biomass processing technology since 1978. In 2009, he joined an MNC company as an advisor for specialty chemicals production and drug design through microbial process technology. He is associated with national and international companies as a technical advisor to produce biopharmaceuticals under cGMP norms. Dr. Behera has authored and edited books with various publishers worldwide.
Bu e-kitaba puan verin
Düşüncelerinizi bizimle paylaşın.
Okuma bilgileri
Akıllı telefonlar ve tabletler
Android ve iPad/iPhone için Google Play Kitaplar uygulamasını yükleyin. Bu uygulama, hesabınızla otomatik olarak senkronize olur ve nerede olursanız olun çevrimiçi veya çevrimdışı olarak okumanıza olanak sağlar.
Dizüstü bilgisayarlar ve masaüstü bilgisayarlar
Bilgisayarınızın web tarayıcısını kullanarak Google Play'de satın alınan sesli kitapları dinleyebilirsiniz.
e-Okuyucular ve diğer cihazlar
Kobo eReader gibi e-mürekkep cihazlarında okumak için dosyayı indirip cihazınıza aktarmanız gerekir. Dosyaları desteklenen e-kitap okuyuculara aktarmak için lütfen ayrıntılı Yardım Merkezi talimatlarını uygulayın.
